Archives — November 2016 back to current month (36)
Trump Makes the U.S. Stock Market Great Again (11/30/2016)
Technical analyst Clive Maund analyzes the charts since Trump's win and sees a positive picture for the U.S. stock market.
A 'Wicked Rally' in Gold Predicted (11/29/2016)
Precious metals expert Michael Ballanger charts recent moves in the gold market and sees a rally in the making.
Central Banks and Their Role in Financial Turmoil (11/29/2016)
Investment advisor Adrian Day comments on the causes and effects of the policies of central banks and regulation on the economy and markets, which were topics of conversation at the recent Cato Monetary Conference.
Osisko Gold Royalties Tracks Gold (11/29/2016)
Bob Moriarty of 321 Gold discusses recent precious metal price movements and Osisko Gold Royalties' leverage to the gold price.
A Sell on a Long-Time Holding (11/29/2016)
Investment advisor Adrian Day discusses his decision to sell shares of American Capital prior to its merger with Ares Capital.
Gold and Silver in Review (11/28/2016)
Gecko Research reviews the past week in gold and charts their actions.
Jack Chan: This Past Week in Gold (11/26/2016)
Technical analyst Jack Chan charts the latest moves in the gold and silver markets.
What Does Trump Mean for Investments? (11/23/2016)
The market reaction to Trump's election victory—stocks and the dollar up, gold down—was the opposite of what had been widely foreseen. Money manager Adrian Day takes a look into what happened and why, and discusses the outlook going forward.
Balmoral Resources Extends Depth of Quebec Deposit (11/23/2016)
Balmoral Resources' announcement that summer drilling has increased the vertical depth of the company's Bug North deposit by 36% prompted a pair of analysts to comment on the company's discovery prospects.
Ben Kramer-Miller, chief analyst at miningWEALTH, profiles Sarama Resources, which he believes is an undervalued explorer run by a world-class exploration team.
BCGold in a Sweet Spot in Peru (11/22/2016)
Bob Moriarty of 321 Gold highlights BCGold, a company that he believes its promising land package in Peru makes it a good buy in this market.
Charting the Post-Election Probabilities for Gold (11/20/2016)
Technical analyst Clive Maund examines the immediate impacts of Donald Trump's presidential victory on the gold market, gold miners and the US dollar.
Silver Sector Buying Opportunity Develops (11/20/2016)
After taking a look at the ups and downs of the silver market pre- and post-election, technical analyst Clive Maund sees a major opportunity developing.
Jack Chan: This Past Week in Gold (11/19/2016)
Technical analyst Jack Chan charts the latest movements in the gold and silver markets, and shows why investors can expect lower prices overall.
Jack Chan: Energy Sector Cycle Turns Up (11/19/2016)
Technical analyst Jack Chan charts a new buy signal in the energy sector.
Torchlight Energy Resources: Update After Breakout (11/19/2016)
Technical analyst Clive Maund reiterates his investment thesis for Torchlight Energy Resources after the stock spikes.
Headline news results in rash decisions; don't let Trump's victory distract you from the bigger picture, says Matt Geiger of MJG Capital. He explains why now is an excellent time to deploy capital into mining equities and highlights seven companies poised to deliver outsized returns.
When the Pendulum Swings (11/17/2016)
Precious metals expert Michael Ballanger equates the position of the financial markets to that of a protagonist in a classic horror story and reflects on recent moves in the copper market.
With the execution of a letter of intent between the company and the chairman of its board, Torchlight Energy will essentially double its working interest in the Hazel Project in the Midland Basin, says Dallas Salazar of ATLAS Consulting, calling the deal one of the single most accretive energy complex transactions dating back to the beginning of the current commodity pricing crisis.
Gecko Research gives its take on the U.S. presidential election and precious metals, and discusses the latest movements at Golden Arrow's Chinchillas JV project in Argentina.
By securing an exclusive option to acquire MirImmune Inc., RXi Pharmaceuticals has expanded its reach into the "high-value" field of immuno-oncology, a move that has energized the company and prompted a pair of analysts to express optimism about RXi's future.
Torchlight Delivers Again and Again (11/14/2016)
Bob Moriarty of 321 Energy disects Torchlight Energy Resources' latest play in the Permian Basin.
This Is What a Mania Looks Like (11/14/2016)
The Trump election has ignited a market mania, but in economic terms, nothing real has changed and the relief probably won't last long, posit Rudi Fronk and Jim Anthony, cofounders of Seabridge Gold.
Jack Chan: This Past Week in Gold, Silver and Copper (11/13/2016)
Technical analyst Jack Chan charts a break in copper, as well as recent movements in the gold and silver markets.
Uranium companies are struggling with the weakness in the uranium market; priced below $20/lb, U3O8 is at levels not seen in well over a decade. But Energy Fuels recently announced two diversification plays that could help insulate it from low uranium prices, and analysts are applauding the news.
All Assets "Bid": Trump Is the New Market Driver (11/10/2016)
Precious metals expert Michael Ballanger reflects on the outlook for gold and silver markets as Donald Trump ascends to the presidency.
The Cannabis Sector after the Vote – Boom or Bust?? (11/08/2016)
Technical Analyst Clive Maund takes a look at the cannabis sector, and how the the election results for eight states, including California, might facilitate a massive boom.
Redstar Waits for Drill Results (11/08/2016)
Bob Moriarty of 321 Gold discusses Redstar Gold Corp. and what investors should expect of the share price during the next few weeks as we await drill results from the company's recently completed 1,500m program at the high-grade Shumagin Gold Zone on Unga Island, Alaska.
California Gold Resource Released (11/07/2016)
Bob Moriarty of 321 Gold updates his investment thesis for California Gold after the company released a new resource report for its gold project at the south end of California's mother lode.
Oil prices have rebounded slightly after speculation about OPEC's ability to cap production later in November and uncertainty surrounding the U.S. presidential election sent them sliding last week, a drop that affected the portfolios of investors across the board.
Dome Forces US Stock Market Lower (11/06/2016)
Technical analyst Clive Maund takes a look at the current state of the U.S. stock market, and reflects on how the outcome of the impending election might steepen a decline.
Jack Chan: This Past Week in Gold (11/05/2016)
Technical analyst Jack Chan charts the latest movements in gold and silver, noting the markets will be volatile until the election is over.
Despite depressed oil prices, Royal Dutch Shell Plc announced strong Q3/16 earnings on Nov. 1. The company attributes the gains, in part, to the now-completed integration of BG Group Plc, which it acquired in February.
Due to drug pricing controversies, there has been much concern about how the outcome of the upcoming election will affect pharmaceutical stocks. Dr. Len Yaffe of Stoc*Doc Partners sheds light on the issues in this analysis of drug price negotiation policy, and focuses in on one California ballot proposition that aims to rein in costs.
Few things can move a stock as quickly as merger and acquisition talk. Resource Maven's Gwen Preston outlines three companies that majors may be eyeing.
The Lithium Boom Has a New Player in Argentina (11/01/2016)
Bob Moriarty of 321 Gold discusses a company that has hit the ground running in Argentina's lithium triangle.
|"AKG has received all permits for the Esaase pit at its Asanko mine."|
|"UEX has discovered a massive unconformity-style uranium mineralization at Christie Lake."|
|"Drill results at MAG's Juanicipio continue to validate the emerging potential of both the Deep Zone and Anticipada vein."|
|"TV is in an excellent position to capture strong zinc fundamentals."|
|"Our valuation of RGS increases with the AGC cash and larger addressable market in Japan partly offset by longer timelines and revised assumptions for CryoShot and Kvax."|